With Medicaid reimbursements representing a significant portion of a pharmacy’s profit, all retail pharmacy organizations are waiting for a final rule to be put in place as created by the Deficit Reduction Act of 2005 (DRA) and later the health care reform act on how reimbursement rates are set. These laws state that the average manufacturer price (AMP) is used to set the Federal Upper Limits (FUL) for generic drugs in the Medicaid program. The intent of Congress was to pay ...

REGISTER TO VIEW THIS ARTICLE - Register for a Free Account

Why Register for FREE?

Registering for content on Supermarket News will give you INSTANT access to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’s FREE, easy and quick.  What are you waiting for! In addition you will also receive a complimentary copy of SN's salary survey sent to you by email.
 

Click here to read the FAQ page if you have any questions (opens in a new window)
 

Attention Paid Print Subscribers:  While you have already been granted free access to SN we ask that you register now. We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.

Already registered? here.